Features

Latest Features

Peripheral Determinants of Oxygen Utilization During Exercise in HFpEF

By

Tori Rodriquez, MA, LPC, AHC

Patients with HFpEF have substantial exercise intolerance, which may be due to peripheral factors.

Screening and Diagnosis of Abdominal Aortic Aneurysms

By

Alicia Elam, PharmD

Abdominal aortic aneurysms are likely to be encountered in the primary care setting, making appropriate diagnosis and management indispensable.

Pulmonary Arterial Hypertension Associated With CHD: Developments in Treatments, Remaining Gaps According to Experts

By

Tori Rodriquez, MA, LPC, AHC

PAH associated with CHD is linked to significant reductions in survival and quality of life, especially for patients progressing to Eisenmenger syndrome.

Treatment Considerations for Thalassemia in the Emergency Department

By

Caleb Rans, PharmD

Antoine N. Saliba, MD, and colleagues summarized current literature surrounding the frequent complications that bring patients with thalassemia into the ED.

Pulmonary Hypertension With ILD: Diagnostic and Treatment Challenges

By

Tori Rodriguez

Although pulmonary hypertension as a result of interstitial lung disease is linked to significant morbidity and mortality, there is no consensus regarding screening or management of the disease.

Explaining Treatment Risks to Patients

By

David Alfandre, MD, MSPH

Physicians should frame treatment options by their “harms and benefits,” not by their “risks and benefits.”

Skeletal Muscle Disease and Cardiometabolic Dysfunction in Rheumatoid Arthritis

By

Amit Akirov, MD

Skeletal muscle alterations in rheumatoid arthritis are often overlooked despite their important role in disability and cardiometabolic disease development.

Sleep Duration and CVD Risk

By

Tori Rodriquez, MA, LPC, AHC

Only 65.2% of adults surveyed in United States in 2014 reported that they consistently get at least 7 hours of sleep each night.

Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19

By

Rita Aghjayan

Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.

Exploring Links Between Depression and Subclinical Atherosclerosis

By

Tori Rodriguez

A substantial body of research points to a multifaceted link between depression and cardiovascular disease, with rates of depression being 3 times higher in patients with CAD.